Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
"Head-to-head studies are the gold standard for clinicians assessing the efficacy of investigational treatments, and these results show that all three doses of tirzepatide delivered superior A1C and weight reductions compared to the highest approved dose of semaglutide to treat type 2 diabetes," said Juan Pablo Fras, M.D., Medical Director, National Research Institute and Principal Investigator of SURPASS-2
This medication became available on the pharmaceutical benefits scheme (PBS) as a subsidised prescription in July 2020
Entenda os efeitos nos fios e na pele
Weight-Related Conditions People with obesity-related conditions, such as type 2 diabetes or metabolic health concerns, are also being studied to understand potential benefits
This article walks through the comparison so you can match the vial size to your research with confidence
US$ 27.40
US$ 24.90
US$ 28.38
US$ 21.12
US$ 22.64
US$ 20.90
US$ 24.18
